ETON
Eton Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$58.45
−2.42%Margins
Gross margin
57.9%
EBITDA margin
17.6%
EBIT margin
15.4%
Net margin
12.0%
FCF margin
14.0%
27.2%
Return on equity
11.0%
Return on assets
21.6%
Return on invested capital
0.99x
Asset turnover
$15.1M
Cash from operations
$0.94
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026